Had a fantastic time at the launch of CaSE 's new report, Backing Business R&D, featuring an insightful speech from Dr Dave Smith! 🧪📊

71% of UK R&D is funded by business but investment stagnating, it's crucial that the UK now fosters an environment that drives

📈 To maximise the success of cancer vaccines, you must select the right targets, with the right modalities, for the right patients.

📃 Read our startup Infintopes’ recent review to find out more: doi.org/mx79

📢 Join The University of Edinburgh’s Venture Builder Incubator and commercialise your research to help beat cancer!

💡 Researchers across the UK can apply to access £100k+ funding, expert mentorship and networking to help launch or scale an oncology startup.

Apply now:

How can we improve the delivery of clinical trials in the UK and beyond? On #ICTD2024 , Dr Lars Erwig explains how the sector can address this issue.

Read more 👉 tinyurl.com/238c3mf2

#CTD2024 #ClincalTrialsDay

🤝 Looking to build your own #oncology startup?

This training is open to anyone (with or without Cancer Research UK ), gives access to industry experts and help to develop business skills. Apply by 14 June  tinyurl.com/3yyh7vuh

Panacea Innovation

#OnMyHorizon

How can we de-risk, scale up, and reduce the cost of steroid synthesis?

Find out in this recent manuscript.

bit.ly/4dzqzWX

Congrats everyone involved @Pharmaron
Lucy Harwood John Taylor
Hossay Abas

#OnMyHorizon #DrugDiscovery #SteroidTherapeutics

🔬 Looking for the right support and resources to translate your #CancerResearch ? Sign up for our newsletter to hear about #entrepreneurial trainings, #funding opportunities & the latest news of the #oncology sector.  Register here: tinyurl.com/yc6am88z

#OnMyHorizon

Where are we most likely to see the next #CancerVaccines breakthrough? 

Something missing? 🤔 Let us know in the comments 👇

#ICYMI , the world's first #CancerVaccine for #Melanoma has entered Phase 3, as announced by MSD and Moderna. Listen to Iain Foulkes discussing this significant advancement on Sky News.

#SkinCancer #mRNA #mRNA vaccine #PersonalizedMedicine

Congratulations J.Kwok and everyone at #Infinitopes ! With a Phase 1/2a #clinicaltrial scheduled for Q3 2024 and innovative proprietary science, your team is poised to deliver the next wave of #CancerVaccine treatments.

#OnMyHorizon Kindred Powerscourt Octopus Ventures

A game-changing FDA approval for #PaediatricCancer 💪
Congrats, Day One Biopharmaceuticals on this achievement!

This is a great step forward in the children and young people’s cancers space.

Read more 👉bit.ly/4aO1PZh

#OrphanDrugDesignation
#ChildhoodCancer

💡 #GenerativeAI is reshaping Pharma! According to McKinsey, it could unlock $60-110 billion annually. Learn more: shorturl.at/kvDF7

#OnMyHorizon #drugdiscovery #machinelearning

McKinsey & Company

Innovation and Entrepreneurship Award for University of Edinburgh and Nuvectis – we have now received a photograph of the winning team🙂 (courtesy of Cancer Research Horizons). Read the full story on our website: ed.ac.uk/cancer-centre/…